Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Prev Med. 2016 Mar 20;88:20–26. doi: 10.1016/j.ypmed.2016.03.016

Table 3.

Association between energy-adjusted vegetable protein intake and gallbladder disease, stratified by history of diabetes or recent weight loss

Subpopulation n events (%) Model 1a
HR (95% CI)
Model 2b
HR (95% CI)
History of diabetes = no
 Quintile 1 2298 (9.1) 1.00 1.00
 Quintile 2 2085 (8.3) 0.93 (0.88–0.99) 0.94 (0.88–1.00)
 Quintile 3 1974 (7.8) 0.88 (0.83–0.93) 0.90 (0.84–0.96)
 Quintile 4 1948 (7.8) 0.86 (0.81–0.92) 0.90 (0.84–0.96)
 Quintile 5 1793 (7.2) 0.78 (0.73–0.83) 0.86 (0.80–0.92)
 Test for trend P < 0.001 P < 0.001
 Continuous 0.85 (0.82–0.88) 0.91 (0.87–0.95)
History of diabetes = yes
 Quintile 1 83 (9.7) 1.00 1.00
 Quintile 2 122 (13.4) 1.49 (1.12–1.98) 1.39 (1.02–1.90)
 Quintile 3 87 (9.6) 1.02 (0.75–1.39) 0.96 (0.68–1.35)
 Quintile 4 117 (11.2) 1.20 (0.90–1.59) 1.08 (0.78–1.47)
 Quintile 5 104 (9.5) 1.02 (0.76–1.36) 1.02 (0.74–1.40)
 Test for trend P = 0.461 P = 0.535
 Continuous 0.96 (0.82–1.12) 0.97 (0.81–1.15)
Recent weight loss > 10%c
 Quintile 1 73 (6.5) 1.00 1.00
 Quintile 2 82 (8.2) 1.28 (0.93–1.77) 1.34 (0.94–1.92)
 Quintile 3 58 (6.8) 1.03 (0.73–1.46) 1.20 (0.82–1.76)
 Quintile 4 69 (7.8) 1.20 (0.86–1.67) 1.23 (0.84–1.79)
 Quintile 5 54 (6.6) 1.01 (0.71–1.44) 1.21 (0.82–1.79)
 Test for trend P = 0.957 P = 0.449
 Continuous 1.05 (0.87–1.28) 1.15 (0.92–1.44)
Recent weight loss ≤ 10%/any gainc
 Quintile 1 1242 (6.4) 1.00 1.00
 Quintile 2 1169 (5.8) 0.93 (0.86–1.01) 0.94 (0.86–1.03)
 Quintile 3 1152 (5.6) 0.90 (0.83–0.98) 0.92 (0.84–1.01)
 Quintile 4 1144 (5.5) 0.88 (0.81–0.96) 0.92 (0.84–1.01)
 Quintile 5 1072 (5.1) 0.81 (0.75–0.88) 0.88 (0.80–0.97)
 Test for trend P < 0.001 P = 0.009
 Continuous 0.86 (0.82–0.91) 0.91 (0.86–0.96)
a

Model 1 is adjusted for age and total energy (log-transformed)

b

Model 2 is further adjusted for BMI, physical activity, neighborhood socioeconomic status, race/ethnicity, oral contraceptive use, hormone therapy use, history of liver disease, statin use, thiazide use, alcohol use, and clinical trial arm(s)

c

Weight loss categories are restricted to women within 25% of their baseline weight at year 3 (data outside that range are likely to be errors). Also, outcomes for this analysis are restricted to time points at year 3 or later.